Citations

Showing 10 of 108152 citations.

A Heparin Sulfate-Regulated Human Keratinocyte Autocrine Factor Is Similar or Identical to Amphiregulin
Cook, Paul W. , Mattox, Paul A., Keeble, Winifred, Pittelkow, Mark R. , Shoyab, M., Adelman, John P. , Shipley, Gary D., Plowman, Gregory D.

Mayo Clinic

Molecular and Cellular Biology | May 31, 2021 | Volume: 11 | Issue: 5 | Pages: 2547-2557

10.1128/mcb.11.5.2547-2557.1991 | PMID 2017164 Get It

Technical Note: 4D robust optimization in small spot intensity‐modulated proton therapy (IMPT) for distal esophageal carcinoma
Feng, Hongying , Shan, Jie , Ashman, Jonathan B. , Rule, William G., Bhangoo, R.S. , Yu, Nathan Y. , Chiang, Jennifer S. , Fatyga, M., Wong, William W. , Chiang, Jennifer, Fatyga, Mirek, Schild, Steven E. , Sio, Terence T. , Liu, Wei

Mayo Clinic

Medical Physics | May 31, 2021 | Volume: 48 | Issue: 8 | Pages: 4636-4647

10.1002/mp.15003 | PMID 34058026 Get It

Purpose To compare the dosimetric performances of small‐spot three‐dimensional (3D) and four‐dimensional (4D) robustly optimized intensity‐modulated proton (IMPT) plans in the presence of uncertainties and interplay effect simultaneously for distal esophageal carcinoma. Method and Materials Thirteen (13) patients were selected and re‐planned with small‐spot ( ~ 2–6 mm) 3D and 4D robust optimization in IMPT, respectively. The internal clinical target volumes (CTV high3d , CTV low3d ) were used in 3D robust optimization. Different CTVs (CTV high4d , CTV low4d ) were generated by subtracting an inner margin of the motion amplitudes in three cardinal directions from the internal CTVs and used in 4D robust optimization. All patients were prescribed the same dose to CTVs (50 Gy[RBE] for CTV high3d /CTV high4d and 45 Gy[RBE] for CTV low3d /CTV low4d ). Dose–volume histogram (DVH) indices were calculated to assess plan quality. Comprehensive plan robustness evaluations that consisted of 300 perturbed scenarios (10 different motion patterns to consider irregular motion (sampled from a Gaussian distribution) and 30 different uncertainties scenarios (sampled from a 4D uniform distribution) combined), were performed to quantify robustness to uncertainties and interplay effect simultaneously. Wilcoxon signed‐rank test was used for statistical analysis. Results Compared to 3D robustly optimized plans, 4D robustly optimized plans had statistically improved target coverage and better sparing of lungs and heart (heart D mean , P = 0.001; heart V 30Gy[RBE] , P = 0.001) in the nominal scenario. 4D robustly optimized plans had better robustness in target dose coverage (CTV high4d V 100% , P = 0.002) and the protection of lungs and heart (heart D mean , P = 0.001; heart V 30Gy[RBE] , P = 0.001) when uncertainties and interplay effect were considered simultaneously. Conclusions Even with small spots in IMPT, 4D robust optimization outperformed 3D robust optimization in terms of normal tissue protection and robustness to uncertainties and interplay effect simultaneously. Our findings support the use of 4D robust optimization to treat distal esophageal carcinoma with small spots in IMPT.
Interleukin 2- and Polyomavirus Middle T Antigen-Induced Modification of Phosphatidylinositol 3-Kinase Activity in Activated T Lymphocytes
Augustine, James A., Sutor, Shari L., Abraham, Robert T.

Mayo Clinic

Molecular and Cellular Biology | May 31, 2021 | Volume: 11 | Issue: 9 | Pages: 4431-4440

10.1128/mcb.11.9.4431-4440.1991 | PMID 1652056 Get It

Reply to Letter to the Editor regarding “Surgical armamentarium for salvage laryngectomy closure reinforcements”
Hayden, Richard E. , Mullin, David, Patel, Andrew K., Nagel, Thomas H. , Howard, Brittany E. , Hinni, Michael L., Lott, David L., Donald, Carrlene B., Chang, Brent A.

Mayo Clinic

Head & Neck | May 31, 2021 | Volume: 43 | Issue: 8 | Pages: 2559-2559

10.1002/hed.26759 | PMID 34057754 Get It

Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: Incidence, patient characteristics, and clinical outcomes
El‐Sabawi, Bassim , Eleid, Mackram F. , Rihal, Charanjit S. , Eleid, Mackram F , Guerrero, Mayra , Nkomo, Vuyisile T. , Pislaru, Sorin V. , Rihal, Charanjit S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | May 31, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ccd.29779 | PMID 34057272 Get It

Intravascular histiocytosis: mimicker of cellulitis, angiosarcoma, inflammatory breast cancer, and others
Johnson, Emma F. , Kelley, Benjamin , Gibson, Lawrence E.

Mayo Clinic

International Journal of Dermatology | May 31, 2021 | Volume: 61 | Issue: 3 | Pages: 306-309

10.1111/ijd.15670 | PMID 34057196 Get It

AbstractBackgroundIntravascular histiocytosis is an underrecognized reactive skin condition characterized by the clinical finding of poorly demarcated erythematous to violaceous patches and plaques. The diagnosis is confirmed by the histologic findings of intraluminal histiocytes on skin biopsy and exclusion of an alternative diagnosis.MethodsA review of patients with a histologic diagnosis of intravascular or intralymphatic histiocytosis and seen at Mayo Clinic, Rochester, Minnesota, from January 1, 2010, to October 10, 2020, was performed. Histologic and clinical information was collected from the medical records.ResultsNine patients were identified. Clinical impressions prior to biopsy varied widely, and no clinician included intravascular histiocytosis in the initial clinical differential diagnosis. Eight patients had preceding trauma to the affected area.ConclusionIntravascular histiocytosis remains a rare skin condition. Clinical identification remains low. Our cases add support to the hypothesis that intravascular histiocytosis is a reactive condition often preceded by trauma and/or surgery.
A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
Zhang, Fan , Petersen, Melissa , Hall, James , Johnson, Leigh , Yaffe, Kristine , Mason, David, Braskie, Meredith N. , Barber, Robert , Mapstone, Mark , Toga, Arthur W. , Team, for the HABLE Study, Toga, Arthur W , O’Bryant, Sid E. , Rissman, Robert A. , Mielke, Michelle M. , Team, for the HABLE Study

Mayo Clinic

Alzheimer's & Dementia | May 31, 2021 | Volume: 18 | Issue: 1 | Pages: 77-87

10.1002/alz.12382 | PMID 34057802 Get It

AbstractIntroductionRepresentation of Mexican Americans in Alzheimer's disease (AD) clinical research has been extremely poor.MethodsData were examined from the ongoing community‐based, multi‐ethnic Health & Aging Brain among Latino Elders (HABLE) study. Participants underwent functional exams, clinical labs, neuropsychological testing, and 3T magnetic resonance imaging of the brain. Fasting proteomic markers were examined for predicting mild cognitive impairment (MCI) and AD using support vector machine models.ResultsData were examined from n = 1649 participants (Mexican American n = 866; non‐Hispanic White n = 783). Proteomic profiles were highly accurate in detecting MCI (area under the curve [AUC] = 0.91) and dementia (AUC = 0.95). The proteomic profiles varied significantly between ethnic groups and disease state. Negative predictive value was excellent for ruling out MCI and dementia across ethnic groups.DiscussionA blood‐based screening tool can serve as a method for increasing access to state‐of‐the‐art AD clinical research by bridging between community‐based and clinic‐based settings.
Increased risk of periprosthetic joint infection after acute, traumatic wound dehiscence following primary total knee arthroplasty
Shirley, Matthew B., Gausden, Elizabeth B. , Abdel, Matthew P. , Sierra, Rafael J.

Mayo Clinic

The Bone & Joint Journal | May 31, 2021 | Volume: 103-B | Issue: 6 Supple A | Pages: 191-195

10.1302/0301-620x.103b6.bjj-2020-2425.r1 | PMID 34053286 Get It

Aims To describe the risk of periprosthetic joint infection (PJI) and reoperation in patients who have an acute, traumatic wound dehiscence following total knee arthroplasty (TKA). Methods From January 2002 to December 2018, 16,134 primary TKAs were performed at a single institution. A total of 26 patients (0.1%) had a traumatic wound dehiscence within the first 30 days. Mean age was 68 years (44 to 87), 38% (n = 10) were female, and mean BMI was 34 kg/m2 (23 to 48). Median time to dehiscence was 13 days (interquartile range (IQR) 4 to 15). The dehiscence resulted from a fall in 22 patients and sudden flexion after staple removal in four. The arthrotomy was also disrupted in 58% (n = 15), including a complete extensor mechanism disruption in four knees. An irrigation and debridement with component retention (IDCR) was performed within 48 hours in 19 of 26 knees and two-thirds were discharged on antibiotic therapy. The mean follow-up was six years (2 to 15). The association of wound dehiscence and the risk of developing a PJI was analyzed. Results Patients who sustained a traumatic wound dehiscence had a 6.5-fold increase in the risk of PJI (95% confidence interval (CI) 1.6 to 26.2; p = 0.008). With the small number of PJIs, no variables were found to be significant risk factors. However, there were no PJIs in any of the patients who were treated with IDCR and a course of antibiotics. Three knees required reoperation including one two-stage exchange for PJI, one repeat IDCR for PJI, and one revision for aseptic loosening of the tibial component. Conclusion Despite having a traumatic wound dehiscence, the risk of PJI was low, but much higher than experienced in all other TKAs during the same period. We recommend urgent IDCR and a course of postoperative antibiotics to decrease the risk of PJI. A traumatic wound dehiscence increases risk of PJI by 6.5-fold. Cite this article: Bone Joint J 2021;103-B(6 Supple A):191–195.
The effectiveness of laboratory tests to predict early postoperative periprosthetic infection after total knee arthroplasty
Uvodich, Mason E. , Dugdale, Evan M. , Osmon, Douglas R. , Pagnano, Mark W. , Berry, Daniel J. , Berry, Daniel J , Abdel, Matthew P.

Mayo Clinic

The Bone & Joint Journal | May 31, 2021 | Volume: 103-B | Issue: 6 Supple A | Pages: 177-184

10.1302/0301-620x.103b6.bjj-2020-2397.r1 | PMID 34053291 Get It

AimsIt remains difficult to diagnose early postoperative periprosthetic joint infection (PJI) following total knee arthroplasty (TKA). We aimed to validate the optimal cutoff values of ESR, CRP, and synovial fluid analysis for detecting early postoperative PJI in a large series of primary TKAs.MethodsWe retrospectively identified 27,066 primary TKAs performed between 2000 and 2019. Within 12 weeks, 169 patients (170 TKAs) had an aspiration. The patients were divided into two groups: those evaluated ≤ six weeks, or between six and 12 weeks postoperatively. The 2011 Musculoskeletal Infection Society (MSIS) criteria for PJI diagnosis in 22 TKAs. The mean follow-up was five years (two months to 17 years). The results were compared using medians and Mann-Whitney U tests and thresholds were analyzed using receiver operator characteristic curves.ResultsWithin six weeks, the median CRP (101 mg/l vs 35 mg/l; p = 0.011), synovial WBCs (58,295 cells/μl vs 2,121 cells/μl; p ≤ 0.001), percentage of synovial neutrophils (91% vs 71% (p < 0.001), and absolute synovial neutrophil count (ANC) (50,748 cells/μl vs 1,386 cells/μl (p < 0.001) were significantly higher in infected TKAs. Between six and 12 weeks, the median CRP (85 mg/l vs 5 mg/l (p < 0.001)), ESR (33 mm/hr vs 14 mm/hr (p = 0.015)), synovial WBCs (62,247 cells/μl vs 620 cells/μl (p < 0.001)), percentage of synovial neutrophils (93% vs 54% (p < 0.001)), and ANC (55,911 cells/μl vs 326 cells/μl (p < 0.001)) were also significantly higher in infected TKAs. Optimal thresholds at ≤ six weeks were: CRP ≥ 82 mg/l (sensitivity 70%, specificity 77%), synovial WBCs ≥ 8,676 cells/μl (83%, 90%), percentage of synovial neutrophils ≥ 88% (67%, 78%), and ANC ≥ 8,346 cells/μl (83%, 91%). Between six and 12 weeks, thresholds were: CRP ≥ 34 mg/l (90%, 93%), synovial WBCs ≥ 1,983 cells/μl (80%, 85%), percentage of synovial neutrophils ≥ 76% (80%, 81%), and ANC ≥ 1,684 cells/μl (80%, 87%).ConclusionEarly PJI after TKA should be suspected within six weeks if the CRP is ≥ 82 mg/l, synovial WBCs are ≥ 8,676 cells/μl, the percentage of synovial neutrophils is ≥ 88%, and/or the ANC is ≥ 8,346 cells/μl. Between six and 12 weeks, thresholds include a CRP of ≥ 34 mg/l, synovial WBC of ≥ 1,983 cells/μl, a percentage of synovial neutrophils of ≥ 76%, and/or an ANC of ≥ 1,684 cells/μl. Cite this article: Bone Joint J 2021;103-B(6 Supple A):177–184.
Mid-term results of tibial cones
Hernandez, Nicholas M. , Wu, Christine J. , Ryan, Sean P. , Bolognesi, Michael P. , Wu, Christine J , Ryan, Sean , Hinton, Zoe W.

Mayo Clinic

The Bone & Joint Journal | May 31, 2021 | Volume: 103-B | Issue: 6 Supple A | Pages: 158-164

10.1302/0301-620x.103b6.bjj-2020-1934.r1 | PMID 34053275 Get It

AimsTibial cones are often utilized in revision total knee arthroplasty (TKA) with metaphyseal defects. Because there are few studies evaluating mid-term outcomes with a sufficient cohort, the purpose of this study was to evaluate tibial cone survival and complications in revision TKAs with tibial cones at minimum follow-up of five years.MethodsA retrospective review was completed from September 2006 to March 2015, evaluating 67 revision TKAs (64 patients) that received one specific porous tibial cone during revision TKA. The final cohort was composed of 62 knees (59 patients) with five years of clinical follow-up or reoperation. The mean clinical follow-up of the TKAs with minimum five-year clinical follow-up was 7.6 years (5.0 to 13.3). Survivorship analysis was performed with the endpoints of tibial cone revision for aseptic loosening, tibial cone revision for any reason, and reoperation. We also evaluated periprosthetic joint infection (PJI), risk factors for failure, and performed a radiological review.ResultsThe rate of cone revision for aseptic loosening was 6.5%, with an eight-year survival of 95%. Significant bone loss (Anderson Orthopaedic Research Institute grade 3) was associated with cone revision for aseptic loosening (p = 0.002). The rate of cone revision for any reason was 17.7%, with an eight-year survival of 84%. Sixteen percent of knees developed PJI following revision. A pre-revision diagnosis of reimplantation as part of a two-stage exchange protocol for infection was associated with both PJI (p < 0.001) and tibial cone revision (p = 0.001).ConclusionMid-term results of tibial cones showed a survivorship free of cone revision for aseptic loosening of 95%. Patients with significant bone loss were more likely to have re-revision for tibial cone failure. Infection was common, and patients receiving cones at reimplantation were more likely to develop PJI and undergo cone revision. Cite this article: Bone Joint J 2021;103-B(6 Supple A):158–164.